Close Menu

NEW YORK – Hologic reported after the close of the market on Wednesday that its fiscal fourth quarter revenues rose 6 percent year over year, driven in part by growth in its medical aesthetics and molecular diagnostics businesses.

For the three months ended Sept. 30, the firm reported total revenues of $865.8 million, up from $813.5 million a year ago and beating the average consensus Wall Street estimate of $845.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.